Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2024-05-23 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Successful Completion of First Cohort
Regulatory Filings Classification · 99% confidence The document is identified by the 'RNS Number' header and contains a date (23 May 2024) and company information (Avacta Group PLC). The content details clinical trial progress (Phase 1 trial for AVA6000), including cohort completion, dosing status, and initiation of a sub-study. This structure—a brief announcement of operational and clinical updates, often referencing inside information and distributed via an RNS service—is characteristic of a general regulatory announcement rather than a comprehensive financial report (like 10-K or IR) or a specific shareholder communication (like DEF 14A). Since it is a general regulatory announcement distributed via RNS that doesn't fit the more specific categories (like DIV, CAP, ER), the most appropriate classification is the general regulatory filing category.
2024-05-23 English
Full Year Results
Earnings Release Classification · 100% confidence The document is an 'Earnings Release' (ER). It explicitly states 'Preliminary Results for the Year Ended 31 December 2023' and provides key financial highlights (revenue, EBITDA, operating loss, EPS) and operational updates. While it contains a Chairman's statement and CEO's statement, it is the initial announcement of the annual financial results, not the full 10-K/Annual Report document itself, and it is not a mere publication announcement (RPA) as it contains substantive financial data. FY 2023
2024-04-30 English
Board Change
Board/Management Information Classification · 99% confidence The document begins with an 'RNS Number' and is explicitly marked as containing 'INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014'. The content announces the appointment of a new Chief Executive Officer (Christina Coughlin) and the stepping down of the previous CEO, including quotes from the Chairman and the incoming CEO. This is a direct announcement regarding senior management changes. This aligns perfectly with the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content dictates the MANG classification over the general RNS fallback.
2024-04-30 English
Block listing Interim Return REPLACEMENT
Regulatory Filings Classification · 99% confidence The document starts with 'RNS Number : 2169M' and mentions 'Avacta Group PLC' and the date '26 April 2024'. It explicitly states, 'The following amendment has been made to the publication of Block Listing Six Monthly Return released on 26/04/24 at 7:00AM under RNS No 1211M.' The content details figures related to unallotted securities under EMI and LTIP schemes, which is typical for a regulatory filing concerning share capital or listing rules compliance. The presence of the RNS header, the reference to AIM Rules for Companies, and the nature of the content (Block Listing Six Monthly Return) strongly suggest this is a regulatory announcement. Since it is a specific regulatory update that doesn't fit perfectly into the other categories (like 10-K, ER, or DIV), the most appropriate classification is the general regulatory filing category, RNS, which serves as a primary information provider announcement mechanism for the London Stock Exchange.
2024-04-26 English
Block Listing Six Monthly Return
Share Issue/Capital Change Classification · 99% confidence The document is identified by the header 'RNS Number : 1211M' and explicitly states it is a notification pursuant to Schedule Six of the AIM Rules for Companies regarding existing block admission arrangements. It details the balance of unallotted securities under the EMI scheme and LTIP scheme over a specific period (28 October 2023 to 27 April 2024). This type of filing, which reports on the status of securities reserved for issuance under employee share schemes, is a routine regulatory disclosure. Since it is a specific regulatory announcement distributed via RNS (London Stock Exchange's news service), and it doesn't fit neatly into the specific categories like Director's Dealing (DIRS), Share Issue (SHA), or Capital Change (CAP) which usually relate to completed transactions or major structural changes, the most appropriate classification is the general regulatory announcement category, RNS, as it is a standard AIM Rule compliance filing.
2024-04-26 English
Block Listing Application to AIM
Share Issue/Capital Change Classification · 99% confidence The document is clearly identified as an RNS announcement by the header 'RNS Number : 6832L' and the closing statement referencing RNS as the news service of the London Stock Exchange. The content announces an 'Application to AIM for a block listing of 6,613,808 ordinary shares' related to the exercise of options under employee share schemes. This is a specific corporate action announcement, not a comprehensive financial report (like 10-K or IR) or a general presentation (like IP). Since it is a formal regulatory announcement distributed via the RNS system that doesn't fit perfectly into the other specific categories (like DIV, SHA, or DIRS), the most appropriate classification is the general regulatory announcement category, RNS.
2024-04-23 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.